A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. All 69 peptides in the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
An investigational once-weekly GLP-1 and glucagon dual agonist from Altimmune, built for a gentler start: its two lower doses were given from the first injection without a dose ramp. In a 48-week phase 2 obesity trial, average weight loss reached 15.6% on the top dose (2.4 mg), and in people with fatty liver it cut liver fat by about half or more within 12 to 24 weeks. Its developer now develops it mainly for liver disease, with a phase 3 trial that began in 2026. Commonly reported: very little yet; it is rarely run outside trials.
With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 0.5 mL (50-unit) U-100 insulin syringe: the low end, 1.2 mg, is 24 units; and the high end, 2.4 mg, is 48 units. 8 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.
Pemvidutide in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.